Focused Ultrasound as a Scalable and Contact-Free Method to Manufacture Protein-Loaded PLGA Nanoparticles

PurposeAlthough nanomaterials are under investigation for a very broad range of medical applications, only a small fraction of these are already commercialized or in clinical development. A major challenge for the translation of nanomedicines into the clinic is the missing scalability of the available lab scale preparation methods and, ultimately, non-identical samples during early and late research.MethodsProtein-loaded PLGA nanoparticles using focused ultrasound in an emulsion solvent diffusion method were prepared in different batch sizes to evaluate achievable mean size, protein loading, and yield.ResultsUsing the same equipment, nanoparticles could be prepared in batch sizes from 1 mg to 2.5 g. Size and yield were directly controllable by the amount of incident energy with good reproducibility. The nanoparticles displayed similar mean size, protein loading, and nanoparticle yield in batch sizes over three orders of magnitude. A scalable purification method based on diafiltration was established.ConclusionsThe proposed method enables for feasibility studies during early research using just a small amount of polymer and protein, while at the same time it allows for larger scale production at later stages. As the proposed method further relies on contact-free energy transmission, it is especially suited for the preparation of clinical research samples.

[1]  B. Conti,et al.  Effects of ionizing radiation sterilization on microparticulate drug delivery systems based on poly-α-hydroxyacids: an overview , 2009 .

[2]  Mary M. Caruso,et al.  Mechanically-induced chemical changes in polymeric materials. , 2009, Chemical reviews.

[3]  Erin Lavik,et al.  The role of nanomaterials in translational medicine. , 2011, ACS nano.

[4]  T. Tadros,et al.  Formation and stability of nano-emulsions. , 2004, Advances in colloid and interface science.

[5]  V. Préat,et al.  PLGA-based nanoparticles: an overview of biomedical applications. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[6]  Y. Schneider,et al.  Targeting nanoparticles to M cells with non-peptidic ligands for oral vaccination. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[7]  Hatem Fessi,et al.  Nanocapsule formation by interfacial polymer deposition following solvent displacement , 1989 .

[8]  D. Hochstrasser,et al.  Colloidal carriers for intravenous drug targeting: Plasma protein adsorption patterns on surface‐modified latex particles evaluated by two‐dimensional polyacrylamide gel electrophoresis , 1993, Electrophoresis.

[9]  Ivo Que,et al.  Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen. , 2010, Vaccine.

[10]  A P Colombo,et al.  Project, Design, and Use of a Pilot Plant for Nanocapsule Production , 2001, Drug development and industrial pharmacy.

[11]  M C Davies,et al.  Detection and determination of surface levels of poloxamer and PVA surfactant on biodegradable nanospheres using SSIMS and XPS. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[12]  María J. Alonso,et al.  Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres , 1997 .

[13]  Andrew L. Zydney,et al.  Bioprocess membrane technology , 2007 .

[14]  M. Donbrow,et al.  Development of acidity in non-ionic surfactants: formic and acetic acid , 1978 .

[15]  K. Caldwell,et al.  Surface Properties of Pluronic-Coated Polymeric Colloids , 1994 .

[16]  Zoltán Kovács,et al.  Mathematical Modeling of Diafiltration , 2009 .

[17]  Richard A Flavell,et al.  Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy. , 2009, Vaccine.

[18]  Hatem Fessi,et al.  Comparative scale-up of three methods for producing ibuprofen-loaded nanoparticles. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[19]  E. Allémann,et al.  Sonication Parameters for the Preparation of Biodegradable Nanocapsulesof Controlled Size by the Double Emulsion Method , 2003, Pharmaceutical development and technology.

[20]  Kurt E. Geckeler,et al.  Polymer nanoparticles: Preparation techniques and size-control parameters , 2011 .

[21]  T. Ebensen,et al.  Non-invasive delivery of nanoparticles to hair follicles: a perspective for transcutaneous immunization. , 2013, Vaccine.

[22]  Christine Vauthier,et al.  Methods for the Preparation and Manufacture of Polymeric Nanoparticles , 2009, Pharmaceutical Research.

[23]  J. Tóth,et al.  Influence of process conditions on the mean size of PLGA nanoparticles , 2011 .

[24]  Mark E. Davis,et al.  Nanoparticle therapeutics: an emerging treatment modality for cancer , 2008, Nature Reviews Drug Discovery.

[25]  G. Reich Ultrasound-induced degradation of PLA and PLGA during microsphere processing: influence of formulation variables. , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[26]  Arthur G Erdman,et al.  The big picture on nanomedicine: the state of investigational and approved nanomedicine products. , 2013, Nanomedicine : nanotechnology, biology, and medicine.

[27]  Amit K Jain,et al.  Engineered PLGA nanoparticles: an emerging delivery tool in cancer therapeutics. , 2011, Critical reviews in therapeutic drug carrier systems.

[28]  B. Kerwin Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: structure and degradation pathways. , 2008, Journal of pharmaceutical sciences.

[29]  H Fessi,et al.  Influence of the stabilizer coating layer on the purification and freeze-drying of poly(D,L-lactic acid) nanoparticles prepared by an emulsion-diffusion technique. , 1998, Journal of microencapsulation.

[30]  René Rietscher,et al.  Semi-Automated Nanoprecipitation-System—An Option for Operator Independent, Scalable and Size Adjustable Nanoparticle Synthesis , 2014, Pharmaceutical Research.

[31]  H. Fessi,et al.  Preparation of redispersible dry nanocapsules by means of spray-drying: development and characterisation. , 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[32]  J. Tóth,et al.  Optimization of protein encapsulation in PLGA nanoparticles , 2011 .